Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)
- Citation:
- J Clin Oncol vol 32 (10) 997-1005
- Year:
- 2014
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pmc-release
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 3
- Parents:
- 959
- Children:
- None
- Program:
- CCP
- Primary Committee:
- Symptom Inter
- Sec. Committees:
- Pharmas:
- Grants:
- CA33601, N01 CA035431, U10 CA035269, CA-37404, U10 CA031946, CA-63844, U10 CA033601, CA-35195, U10 CA037404, U10 CA035448, U10 CA063848, U10 CA035195, CA-35103, CA-25224, N01 CA063844, CA-35113, U10 CA035101, U10 CA035113, P30 CA015083, CA-63848, U10 CA035415, U10 CA063849, CA-35415, U10 CA035431, CA-35269, CA-35448, CA-35101, U10 CA025224, CA31946, U10 CA063844, CA-63849, U10 CA035103
- Corr. Author:
- Charles L. Loprinzi
- Authors:
- Charles L. Loprinzi Rui Qin Shaker R. Dakhil Louis Fehrenbacher Kathleen A. Flynn Pamela Atherton Drew Seisler Rubina Qamar Grant C. Lewis Axel Grothey
- Networks:
- Study
- NCCTG-N08CB
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Gic5, Psc2, Psc5, Cmpl4, ORIGINAL REPORTS, Rapid Communications